Where is Nucleai headquartered?

Nucleai is located in Tel Aviv, Tel Aviv.

Who invested in Nucleai?

Nucleai has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Nucleai?

Nucleai closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

nucleaimd.com

Nucleai

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.

Business Model:

Revenue: $0

Employees: 11-50

Geographic Data

Address:

City: Tel Aviv

State: Tel Aviv

Zip:

Country: Israel

Financial Info

Stage:

series b

Raised Last:

$33M

Raised Total:

$47M

Social

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2022	Series B		$0	Debiopharm Innovation Fund Fosun RZ Capital Grove Ventures Sanofi Ventures Section 32 Vertex Ventures Israel Debiopharm Innovation Fund Fosun RZ Capital Grove Ventures Sanofi Ventures Section 32 Vertex Ventures Israel
3/2018	Seed Round	3	$5M	Grove Ventures Grove Ventures Vertex Ventures Israel Nir Kalkstein Grove Ventures Grove Ventures Vertex Ventures Israel
7/2020	Series A		$0	Vertex Ventures Israel Grove Ventures Debiopharm Innovation Fund Debiopharm Innovation Fund Vertex Ventures Israel Grove Ventures Debiopharm Innovation Fund Debiopharm Innovation Fund
3/2022	Series B	6	$33M	Debiopharm Innovation Fund Fosun RZ Capital Grove Ventures Sanofi Ventures Section 32 Vertex Ventures Israel Debiopharm Innovation Fund Fosun RZ Capital Grove Ventures Sanofi Ventures Section 32 Vertex Ventures Israel
7/2020	Series A	3	$8.5M	Vertex Ventures Israel Grove Ventures Debiopharm Innovation Fund Debiopharm Innovation Fund Vertex Ventures Israel Grove Ventures Debiopharm Innovation Fund Debiopharm Innovation Fund

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details